Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

NOVARTIS

  • FDA Approval
  • Oct. 05, 2022, 10:02 UTC
  • 28
  • 0 comments

FDA approve OCTREOTIDE ACETATE

Comment Full text

UNICHEM

  • FDA Approval
  • Oct. 05, 2022, 01:36 UTC
  • 29
  • 0 comments

FDA approve LOSARTAN POTASSIUM

Comment Full text

ASTRAZENECA

  • FDA Approval
  • Oct. 05, 2022, 01:36 UTC
  • 24
  • 0 comments

FDA approve OMEPRAZOLE MAGNESIUM

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Oct. 05, 2022, 01:36 UTC
  • 25
  • 0 comments

FDA approve BRIVARACETAM

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Oct. 05, 2022, 01:36 UTC
  • 24
  • 0 comments

FDA approve CLOFARABINE

Comment Full text

ALNYLAM PHARMS INC

  • FDA Approval
  • Oct. 05, 2022, 01:36 UTC
  • 27
  • 0 comments

FDA approve PATISIRAN SODIUM

Comment Full text

TEVA PHARMS

  • FDA Approval
  • Oct. 04, 2022, 10:03 UTC
  • 28
  • 0 comments

FDA approve ELTROMBOPAG

Comment Full text

ALNYLAM PHARMS INC

  • FDA Approval
  • Oct. 04, 2022, 09:48 UTC
  • 25
  • 0 comments

FDA approve PATISIRAN SODIUM

Comment Full text

NOVARTIS

  • FDA Approval
  • Oct. 04, 2022, 09:45 UTC
  • 25
  • 0 comments

FDA approve LETROZOLE; RIBOCICLIB SUCCINATE

Comment Full text

NOVARTIS

  • FDA Approval
  • Oct. 04, 2022, 09:42 UTC
  • 25
  • 0 comments

FDA approve RIBOCICLIB SUCCINATE

Comment Full text
  • Previous
  • 973
  • 974
  • 975
  • 976
  • 977
  • Next

Search

News categories

  • Technical Exchange News(12342)
  • Event(6229)
  • SEC News(270229)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(157486)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin